collaborators

17 papers

cs.CV2026

Bayesian adaptively-weighted ensembles for few-shot abdominal segmentation

Abbas Al-Sabbagh, Shalom F. Mushtaq, Tomás M. da Silva +7

Few-shot learning has emerged as a promising approach for anatomical segmentation when labelled data are scarce. However, different few-shot learning algorithms exhibit complementa…

cs.CV2026

Active few-shot segmentation by reinforcing data selection

Chenlan Zhao, Benny Wong, Timothy F. Lundberg +8

Few-shot learning enables medical image segmentation models to adapt to new tasks using only a small number of labelled examples. However, adaptation performance depends strongly o…

cs.CV2026

Bridging Single Distortion Artifacts and Multifactorial Clinical Quality: Few-shot Biparametric MRI Quality Assessment via Distortion-trained Prototypical Networks

Yucheng Tang, Alexander Ng, Wen Yan +11

Clinical prostate multi-parametric MRI relies heavily on high-quality diffusion-weighted imaging (DWI), yet reading DWI is frequently compromised by geometric distortion, often cau…

cs.CV2026

Interpretable Probabilistic Medical Image Segmentation via Gaussian Process with Explicit Modelling of Annotation Bias and Variability

Qi Li, Yuliang Huang, Shaheer U. Saeed +7

Deep learning-based medical image segmentation models are trained using annotations that exhibit systematic bias and variability across raters. While probabilistic multi-rater appr…

cs.CV2026

Learning to Distort: Weakly-Supervised Image Quality Transfer for Prostate DWI Correction

YuCheng Tang, Wen Yan, Alexander Ng +13

Single-shot echo-planar prostate diffusion-weighted imaging (DWI) is frequently complicated by geometric distortions, which impact the ability to derive reliable diagnoses from suc…

cs.CV2026

Radiomics-Integrated Deep Learning with Hierarchical Loss for Osteosarcoma Histology Classification

Yaxi Chen, Zi Ye, Shaheer U. Saeed +4

Osteosarcoma (OS) is an aggressive primary bone malignancy. Accurate histopathological assessment of viable versus non-viable tumor regions after neoadjuvant chemotherapy is critic…